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Cancer of the cervix is the second most common cancer in 
women in South Africa, and the most common cancer in 
women aged 15 - 29 years and 30 - 54 years, accounting for 
12.5% and 25.7% respectively.1
A National Screening Policy was instituted in South Africa in 
2001.2 The State health system will pay for three cervical smear 
tests in a lifetime, commencing at the age of 30. Screening 
coverage has been shown to be more important than interval of 
screening in Scandinavian countries.3 Cytological screening for 
cervical cancer in Johannesburg primary health care facilities 
has achieved 20% coverage4 and there is a commitment to 
increase this. Papanicolaou smear screening and treatment 
of premalignant cervical abnormalities was shown to 
reduce the incidence of cervical cancer in Europe and North 
America.5 There are few dedicated clinics for the treatment 
of premalignant disease of the cervix in South Africa. A one-
stop clinic for diagnosis and treatment is a very attractive 
alternative in our setting. Compliance is a concern at our 
clinic. Out of 231 booked patients, 80 (34.6%) did not attend 
in the first 6 months of 2005. Loss to follow-up was assessed 
at an audit done in September 2005; this showed that 9.9% of 
patients did not come back for their histology results and 38.5% 
did not come back for a 6-month Pap smear after treatment.6 
The workload at the colposcopy clinic has increased over the 
last 2½ years because of the increase in the number of referrals 
to the colposcopy clinic. There was a long delay after the Pap 
smear in patients accessing the colposcopy clinic (Fig. 1). The 
range was between 14 and 706 days, with half of the patients 
arriving by 104 days.6
In South Africa cancer of the cervix and AIDS are both 
endemic. The incidence of cervical intraepithelial neoplasia 
(CIN) is between 50% and 70% in patients who are HIV 
infected in Africa.7,8 One would have anticipated an increase in 
the prevalence of cervical cancer but this has not yet occurred. 
It is possible that HIV-infected women die from other causes 
before they develop cancer of the cervix. With the rollout 
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Objectives. An audit was undertaken of a ‘colposcopy 
and treatment’ clinic between April 2003 and December 
2006, to determine: (i) the frequency of overtreatment 
with Papanicolaou smear on its own, colposcopy on its 
own or a combination of the two methods; (ii) differences 
in overtreatment between patients who are HIV positive 
and those who are HIV negative; and (iii) the short-
term complications of Lletz (large loop excision of the 
transformation zone) at this clinic.
Design. A retrospective analysis of data from the colposcopy 
clinic database of patients, who were referred according to 
national guidelines.
Setting. Patients who are referred to Chris Hani Baragwanath 
Hospital.
Results.  Normal histology was found in 1.3% of patients, 
and cervical intraepithelial neoplasia (CIN) 1 or human 
papillomavirus (HPV) in 8.4%. The overall complication rate 
was 3%.
Conclusion. The high loss to follow-up and the low early 
complication rate together with an acceptable overtreatment 
rate make this a justifiable approach in our situation. HIV-
negative women were more likely to be overtreated than HIV-
positive patients (p=0.03).  
S Afr Med J 2008; 98: 119-122.
0
50
100
150
200
apr-
jul
aug-
nov
dec-
mar
apr-
jul
aug-
nov
dec-
mar
apr-
jul
aug-
nov
dec-
mar
apr-
jul
aug-
nov
Referrals (April 2003-November 2006)
Fig. 1.  Four-monthly referrals to colposcopy clinic, April 2003 - 
November 2006.
pg119-122.indd   119 1/22/08   12:39:59 PM
February 2008, Vol. 98, No. 2  SAMJ
ORIGINAL ARTICLES
120
of antiretroviral drugs, cervical cancer may become more 
prevalent in HIV-positive patients. 
Methods
The study was designed to assess the degree of overtreatment 
and undertreatment by correlating cytology, colposcopy and 
histology. The incidence of complications in the short term 
was also considered. The difference in overtreatment in HIV-
positive as opposed to HIV-negative women was evaluated.
Information was obtained from a colposcopy database 
which was created for audit purposes. This was therefore 
a retrospective analysis of routinely collected data. The 
University of the Witwatersrand Ethics committee approved 
the study.
Patients
Between April 2003 and December 2006, 1 252 patients were 
referred to Chris Hani Baragwanath Hospital. Patients were 
excluded from the analysis if there was a lack of cytological 
and colposcopic evidence of CIN, pregnancy, histological 
evidence (e.g. punch biopsy) of CIN or if colposcopy was not 
possible. There were 922 patients who were included in the 
analysis. All of these women had a large loop excision of the 
transformation zone (Lletz) or cold-knife cone. 
All patients with a Pap abnormality grade worse than 
low-grade squamous intra-epithelial lesion (LG SIL), atypical 
squamous cells of unknown significance which persisted 
for longer than 6 months, clinical suspicion of a malignancy 
in the presence of a normal Pap smear, and HIV-infected 
patients with an ASCUS or worse are referred to the clinic 
for colposcopy. Patients are given a written explanation 
of abnormalities of the Pap smear and possible treatments 
including outpatient Lletz and its complications. They are 
then counselled and given the choice of whether to have 
the Lletz procedure done under general or local anaesthetic. 
The vast majority, 892 (96.6 %) patients, have chosen to have 
the procedure done under local anaesthetic, while 30 (3.4%) 
patients (almost all by choice) had a Lletz or cold-knife cone 
performed under general anaesthesia.
A Lletz is performed on all patients with CIN 2 or higher on 
Pap smear or colposcopy, CIN 1 or higher in patients who are 
HIV infected, where the colposcopy is inadequate, and when 
there is a discrepancy between colposcopy and cytology by one 
grade. 
The Lletz procedure
A colposcopy is performed using the saline technique. A 
cervical block is performed using a dental syringe with 2% 
lignocaine and 1 in 100 000 adrenaline. The loop size is chosen 
according to the size of the lesion and the transformation 
zone. Patients are then followed up with cervical smears at 6-
monthly intervals for 3 smears and annually thereafter.
Results
Age 
The patients’ ages ranged from 18 to 82 with a mean of 38.7 
and a median of 35.
Parity
There were 84 (9.1%) nulliparous patients, 245 (26.6%) who 
had had one pregnancy and 593 (64.2%) women who were 
multiparous. 
HIV status 
Two hundred and twenty (23.8%) women were HIV-negative, 
464 (50.4%) had a documented HIV-positive test result and the 
HIV status of 238 (25.8%) women was unknown.
Correlation between cytology and histology 
(Table I)
The correlation between Pap smear and histology was exact in 
71.8%. The prediction was better with the higher grades. We 
considered it an undercall when Pap showed normal, ASCUS, 
LG SIL, or atypical squamous cells cannot exclude HG SIL 
(ASC-H) in the presence of histology of CIN 2 or worse. The 
rate of undercall with Pap smears in this group was 15.4%. The 
overcall for cytology was 5.6%. Of concern was the finding 
that the Pap smear reflected ASC-H or HG SIL in 2.1% of cases 
where invasive cancer was found on histology.
Correlation between colposcopy and histology 
(Table II)
There was exact correlation between colposcopy and histology 
in 80.2%. The undercall (less than CIN 2 on colposcopy and 
more than CIN 1 on histology) with colposcopy was 5.8%.  
There was a 0.8% finding of invasion when the colposcopy 
diagnosis was CIN 2 or CIN 3.
The overcall (more than CIN 1 on colposcopy and less than 
CIN 2 on histology) was 7.5%. 
Overtreatment
To calculate the overtreatment in this population, we used 
the US National Cancer Institute definition of overtreatment, 
in which the appropriate treatment threshold is a diagnosis 
of HG SIL or worse, and the numerator is the number of 
patients who were treated and found to have normal or LG 
SIL on histological diagnosis.9 Table III reflects the weighted 
percentages using the above definition.
A positive colposcopy was defined as reflecting an 
assessment of CIN 2 or worse, a positive Pap smear as HG SIL 
or more severe and negative histology as being normal, CIN 1 
or human papillomavirus (HPV) only. Overtreatment was not 
significantly different whether Pap and/or colposcopy were 
used to decide on treatment.
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HIV-negative women were more likely to be overtreated 
than HIV-positive women (Table IV).
Complications
Clearly only patients who returned for follow-up could be 
assessed in this regard. There were 79 (2.7%) patients who 
returned with excessive bleeding, infection or pain. There were 
38 patients with haemorrhage of whom 2 were admitted for 
suturing in theatre. There were 34 patients with infection and 1 
required a laparotomy for a pelvic abscess. 
Discussion
The main criticism of the ‘see-and-treat’ approach is the risk of 
overtreatment. Quoted rates of overtreatment range between 
13% and 72%.10,11 These studies differed as regards referral 
patterns and the definition of overtreatment. 
Most of the patients who were referred to our clinic had HG 
SIL, and we found a better overall correlation with Pap and/or 
colposcopy when HG lesions were reported at histology. 
The patients with equivocal smears (ASCUS, ASC-H or LG 
SIL) that were referred to our clinic all either had persistent 
abnormalities or were immunocompromised. There were 
189 (20.5%) such cases, 46 (4.9%) of whom had CIN 1, HPV 
or normal histology, and the remainder had CIN 2 or worse. 
HPV testing would probably not have helped reduce the 
overtreatment in this group. HPV testing is less specific than 
Pap smear.12 
Table I. Correlation between cytology and histology (N (%)) 
        Histology     
Pap          Normal      CIN 1          CIN 2  CIN 3         Micro-invasion         Invasion Totals for Pap
Normal          0 (0.0)      1 (0.1)    1 (0.1)    0 (0.0)  0 (0.0)             0 (0.0)       2 (0.2)
ASCUS          2 (0.2)      5 (0.5)  10 (1.1)    5 (0.5)  0 (0.0)             0 (0.0)     22 (2.4)
ASC-H          1 (0.1)    12 (1.3)  27 (2.9)  38 (4.1)  2 (0.2)             1 (0.1)      81 (8.8)
AGUS          0 (0.0)      0 (0.0)    5 (0.5)    1 (0.1)  0 (0.0)             0 (0.0)       6 (0.7)
LG SIL          1 (0.1)    26 (2.8)  38 (4.1)  20 (2.2)  0 (0.0)             1 (0.1)     86 (9.3)
HG SIL          8 (0.9)    43 (4.7)                 253 (27.4)                370 (40.1)  7 (0.8)             9 (1.0)    690 (74.8)
Malignant
cells           0 (0.0)      0 (0.0)    2 (0.2)  19 (2.1)  3 (0.3)             1 (1.2)     35 (3.8)
Totals for             
histology         12 (1.3)    87 (9.4)                336 (36.4)                453 (49.1)                12 (1.3)           22 (2.4)    922 (100)
CIN = cervical intra-epithelial neoplasia; ASCUS = atypical squamous cells of unknown significance; ASC-H = atypical squamous cells suggesting a high-grade lesion; AGUS = atypical 
glandular cells of unknown significance; LG SIL = low-grade squamous intra-epithelial lesion; HG SIL = high-grade squamous intra-epithelial lesion.
Table II. Correlation between colposcopy and histology (N (%)) 
          Histology               
Colposcopy          Normal          CIN 1                     CIN 2     CIN 3           Micro-invasion          Invasion        Totals for colposcopy
Normal              1 (0.1)         2 (0.2)     3 (0.3)      0 (0.0)  0 (0.0)          0 (0.0)         6 (0.7)
CIN 1              1 (0.1)       26 (2.8)   32 (3.5)    18 (2.0)  0 (0.0)          0 (0.0)       77 (8.4)
CIN 2              6 (0.7)       40 (4.3) 166 (18.0)  171 (18.5)  4 (0.4)          3 (0.3)     390 (42.3)
CIN 3              4 (0.4)       18 (2.0) 128 (13.9)  238 (25.8)  5 (0.5)          5 (0.5)     398 (43.2)
Micro-
invasion              0 (0.0)         1 (0.1)     6 (0.7)    25 (2.7)  3 (0.3)          7 (0.8)                    42 (4.6)
Invasion              0 (0.0)         0 (0.0)     1 (0.1)      1 (0.1)  0 (0.0)          7 (0.8)         9 (1.0)
Totals for
histology            12 (1.3)            87 (9.4)               336 (36.4)                  453 (49.1)                12 (1.3)        22 (2.4)      922 (100)
CIN = cervical intra-epithelial neoplasia.
Table IV. Overtreatment using the US definition
Overtreatment for abnormal  Pap  7.7%
Overtreatment for abnormal colposcopy  8%
Overtreatment for Pap and colposcopy  6.7%
Overtreatment for abnormal Pap or colposcopy 8.9%
Table III. Overtreatment by HIV infection
      HIV
  HIV infected uninfected
  N=464  N=220           p-value
Normal  
histology       6 (1.3)    4 (1.8)           0.03
CIN 1 and/or HPV    39 (8.4)  30 (13.6) 
CIN = cervical intraepithelial neoplasia; HPV = human papillomavirus.
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The rates of overtreatment were similar for colposcopy, Pap 
or a combination of the two. However colposcopy did aid in 
assessing the transformation zone and the size of the lesion. 
Pap followed by Lletz without colposcopy may be considered 
as an option in high-prevalence areas. 
There was a more liberal referral of patients who are HIV 
infected to the colposcopy clinic.  Patients who were HIV 
positive were referred to the clinic with less severe cytology 
findings, reflecting uncertainty as regards prognosis. 
It has been shown that punch biopsy does not reduce the 
occurrence of negative Lletz, and may be unreliable. It cannot 
be regarded as representing the gold standard.13 Selecting 
treatment on the basis of colposcopically directed punch biopsy 
may not be accurate.10 
Failure to diagnose micro-invasive and invasive lesions was 
also of concern.
There were 17 out of 922 (1.8%) cases of micro-invasion or 
invasion not detected at colposcopy and 20 out of 922 (2.2%) 
cases not detected by Pap smear. These figures are similar to 
those reported in other series of ‘see-and-treat’ clinics.14,15
Conclusions
In this population with a high prevalence of both CIN and HIV, 
a ‘see-and-treat’ approach is justifiable.
The early complication rate was acceptably low, and 
management was appropriate in terms of over- and 
undertreatment, and it should be noted that overtreatment on 
the basis of cytology alone would have occurred in 11.1%. 
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